Press Releases

TINLEY PARK, Ill., Dec. 19, 2019 /PRNewswire/ -- Hematogenix® announces the opening of their newest facility in Shanghai, China furthering their commitment to be a global leader in the field of cancer research and diagnostic testing. China's growing population is attractive to the pharmaceuti

NEW YORK, Dec. 19, 2019 /PRNewswire/ -- A recent report published by KLAS ranks CipherHealth as one of the top three most closely aligned vendors in how it supports heal

NASHVILLE, Tenn., Dec. 19, 2019 /PRNewswire/ -- Tivity Health® (Nasdaq: TVTY), a leading provider of nutrition, fitness and social engagement solutions, and the parent company of SilverSneakers®, which offers health, wellness and social connectivity to seniors at more than 16,000 locations nationwide, has declared senior isolation and loneliness a

SAN DIEGO, Dec. 19, 2019 /PRNewswire/ -- Truvian Sciences ("Truvian") will celebrate today the official debut of the company's new 36,000 square-foot headquarters in Univers

HAMPTON, N.H., Dec. 19, 2019 /PRNewswire/ -- Planet Fitness, Inc., one of the largest and fastest-growing franchisors and operators of fitness centers in the U.S., is calling "bullfit" on the current state of the fitness industry with bold new research that uncovers Americans' true feelings and misperceptions about health and wellness. In the aptly titled "

CONCORD, N.H., Dec. 19, 2019 /PRNewswire/ -- Tufts Health Freedom Plan announced today it will provide access to unlimited acupuncture coverage for members with fully insured commercial plans,

BOSTON, Dec. 19, 2019 /PRNewswire/ --  

SACRAMENTO, Calif., Dec. 19, 2019 /PRNewswire/ -- On December 11, the Petco Foundation presented the Sacramento SPCA with a Holiday Wishes grant in the amount of $10,000 at the Petco Store located in Folsom, CA.  The award was given thanks to an adoption

LOS ANGELES, Dec. 19, 2019 /PRNewswire/ -- CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company, today highlighted Orphazyme A/S received FDA Breakthrough Therapy Designation for arimoclomol for NPC. Breakthrough Therapy Designation is a program intended to expedite the development and review of drugs to treat serious or life-threate

SAN FRANCISCO, Dec. 19, 2019 /PRNewswire/ -- Benchling, the leading life sciences R&D cloud platform, announced a record-breaking year, adding more than 150 new clients to its roster with significant expansion of enterprise customers in 2019. The company has more than doubled its customer base for the past two years to fuel key breakthroughs in biopharmaceuticals, biofuels, biomaterials